Has Ted Lao, MD received payments from drug or device companies?

Yes. Drug and device makers reported $19,438 in general payments to Ted Lao, MD across 53 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Ted Lao, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Ted Lao, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Ted Lao, MD

Nephrology · New York, NYNPI 1073007712

Payments from drug & device makers

$19,438in general payments, 2019–2025

Across 53 payments — averaging $366.76 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Angiodynamics, Inc.$15K
Medtronic$1K
AstraZeneca$943
Aurinia Pharma U.S., Inc.$584
Bard Peripheral Vascular, Inc.$405
Travere Therapeutics, Inc.$266
plus $1K from 7 others

What the payments were for

Travel & lodging$4722%
Food & beverage$3,96620%
Other$15,00077%

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Angiodynamics, Inc.	2	$15,000
Medtronic	11	$1,076
AstraZeneca(2 entities)	13	$943
Aurinia Pharma U.S., Inc.	7	$584
Bard Peripheral Vascular, Inc.	5	$405
Travere Therapeutics, Inc.	2	$266
Otsuka America Pharmaceutical, Inc.	2	$250
Amgen(2 entities)	2	$240
Globus Medical	2	$238
Abbott	3	$218
Advanced Oxygen Therapy Inc.	2	$181
Lemaitre Vascular, Inc.	1	$21
Vifor Pharma, Inc.	1	$16

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

Auryon Laser System 100-120 Vac$15,000
ELLIPSYS VASCULAR ACCESS SYSTEM$699
LUPKYNIS$513
LOKELMA$371
ULTOMIRIS$258
KRYSTEXXA$240
Senza$182
Diamondback Coronary$158
Topical oxygen chamber for extremities$149
JYNARQUE$125
FARXIGA$122
VENOVO$113

How this compares

$19,438 in reported general payments places this provider in the 85th percentile of 935 nephrology providers in New York.

See all nephrology providers in New York →

Medicare billing

Part B allowed, 2024

$47,868

Medicare patients

207

Services billed

363

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other nephrology in New York

Joji TokitaNew York$8.4M
Krzysztof KirylukNew York$6.7M
David BernardNew York$6M
Andrew BombackNew York$3.4M
Pietro CanettaNew York$3.2M
Gerald AppelNew York$1.5M
David CharytanNew York$1.3M
Kirk CampbellNew York$1.1M
Jai RadhakrishnanNew York$995K
Girish NadkarniNew York$978K

See the full list for New York →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →